Workplace safety is a huge topic subject to legal oversight. In 1970, Congress passed the Occupational Safety and Health Act to help protect workers from workplace issues that posed serious threats to their health and safety. For years, labor-intensive industries were the primary targets of Occupational Safety and Health Administration (OSHA) regulators. However, because healthcare industry has one of the highest rates of occupational accidents and illnesses, long-term care facilities in particular are now common inspection sites.
CMS announced on November 17 that individuals from 7,313 nursing homes have completed the CMS COVID-19 training. This accounts for 12.5% of the approximately one million nursing home staff in the country. CMS is calling on all nursing homes to take action and require staff to complete this free training.
While we have all been living with the COVID-19 pandemic for a majority of 2020, the flu season is now upon us as well. As both the flu and COVID-19 share commonalities, it can be difficult to determine the difference when residents are showing symptoms, but it’s vital that staff be ready to differentiate and address both.
Reporting requirements for nursing homes are constantly changing during the pandemic. CMS has been updating requirements weekly, and sometimes daily, so it can be difficult for SNFs to keep track of what exactly they need to report and when they need to report it.
With us today is Joan Usher, a nationally recognized expert in the field of health information management. Find her at jluhealth.com. Today, we’ll be talking about HIPAA, the public health emergency, how to handle staff COVID testing in a HIPAA-compliant way, and more.
CMS issued updated SNF visitation guidance on September 17. The new guidance lays out a plan addressing when and how SNFs should begin allowing visitors in their facility again, based on community spread and resident health.
A plethora of laboratories across the United States are rapidly producing COVID-19 tests, but a recent record check by CMS resulted in 171 cease and desist letters to labs, halting production of tests at labs without the proper qualifications.